Welcome to the School of Engineering and Materials Science
All our undergraduate programmes are ranked as some of the highest in the UK and among the best in London. Our taught postgraduate programmes are similarly first class and provide students with a fantastic opportunity to engage with cutting-edge research focused in: Modelling and Simulation in Engineering Systems, Bioengineering and Materials Science. The skills developed by our students and our extensive industrial connections provide graduates with excellent employability in stimulating and well-paid careers. The School of Engineering and Materials Science (SEMS) provides outstanding degree programmes coupled with internationally leading research.
Queen Mary University of London is a Russell Group university. We are ranked 9th in the UK for research and provide an attractive campus environment within the heart of London.
|Tue 16 - Fri 19 Feb 16||Engineering Spring School|
|Wed 17 Feb 16||ELC meeting|
|Wed 17 Feb 16||Study Abroad SEB|
|Mon 22 Feb 16||Discipline Teaching Group for Medical Engineering|
|Tue 23 Feb 16||School Strategy & Policy Group Meeting|
|Wed 24 Feb 16||Seminar: The Lifetimes of Evaporating Droplets and Related Problems by Prof Stephen Wilson|
|Thu 25 Feb 16||What is Bioengineering?|
- Berardo A, Pantano MF and Pugno NM Slip knots and unfastening topologies enhance toughness without reducing strength of silk fibroin fibres Interface Focus vol. 6, (1)
- Thompson CL, Wiles A, Poole CA and Knight MM Lithium chloride modulates chondrocyte primary cilia and inhibits Hedgehog signaling. FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 30, (2) 716-726.
- Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG and Planat V International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy vol. 18, (2) 151-159.